NAMPT and metabolic dysfunction-associated steatotic liver disease: Adipokines disbalance, such as dysregulation in level of adiponectin, leptin, resistin, chemerin, visfatin and some others, have been identified as a factor increasing fibrosis progression, inflammation and steatosis in chronic liver diseases including NAFLD/NASH, CHB and alcoholic liver disease (ALD) [4–9].